[1]
|
Wang, W., Jiang, B., Sun, H., Ru, X., Sun, D., Wang, L., et al. (2017) Prevalence, Incidence, and Mortality of Stroke in China. Circulation, 135, 759-771. https://doi.org/10.1161/CIRCULATIONAHA.116.025250
|
[2]
|
Ning, X., Sun, J., Jiang, R., Lu, H., Bai, L., Shi, M., et al. (2017) Increased Stroke Burdens Among the Low-Income Young and Middle Aged in Rural China. Stroke, 48, 77-83. https://doi.org/10.1161/strokeaha.116.014897
|
[3]
|
Bäckhed, F., Ley, R.E., Sonnenburg, J.L., Peterson, D.A. and Gordon, J.I. (2005) Host-Bacterial Mutualism in the Human Intestine. Science, 307, 1915-1920. https://doi.org/10.1126/science.1104816
|
[4]
|
Barko, P.C., Mcmichael, M.A., Swanson, K.S. and Williams, D. (2018) The Gastrointestinal Microbiome: A Review. Journal of Veterinary Internal Medicine, 32, 9-25. https://doi.org/10.1111/jvim.14875
|
[5]
|
Lynch, S.V. and Pedersen, O. (2016) The Human Intestinal Microbiome in Health and Disease. The New England Journal of Medicine, 375, 2369-2379. https://doi.org/10.1056/nejmra1600266
|
[6]
|
Reimann, F. and Gribble, F.M. (2016) Mechanisms Underlying Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 Secretion. Journal of Diabetes Investigation, 7, 13-19. https://doi.org/10.1111/jdi.12478
|
[7]
|
Grasset, E., Puel, A., Charpentier, J., Collet, X., Christensen, J.E., Tercé, F., et al. (2017) A Specific Gut Microbiota Dysbiosis of Type 2 Diabetic Mice Induces GLP-1 Resistance through an Enteric NO-Dependent and Gut-Brain Axis Mechanism. Cell Metabolism, 26, 278. https://doi.org/10.1016/j.cmet.2017.06.003
|
[8]
|
Ankit, G., Jelinek, H.F. and Hayder, A.-A. (2017) Glucagon Like Peptide-1 and Its Receptor Agonists: Their Roles in Management of Type 2 Diabetes Mellitus. Diabetes & Metabolic Syndrome, 11, 225-230.
https://doi.org/10.1016/j.dsx.2016.09.003
|
[9]
|
Færch, K., Torekov, S.S., Vistisen, D., Johansen, N.B., Witte, D.R., Jonsson, A., et al. (2015) GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study. Diabetes, 64, 2513-2525. https://doi.org/10.2337/db14-1751
|
[10]
|
Psichas, A., Sleeth, M.L., Murphy, K.G., Brooks, L., Bewick, G.A., Hanyaloglu, A.C., et al. (2015) The Short Chain Fatty Acid Propionate Stimulates GLP-1 and PYY Secretion via Free Fatty Acid Receptor 2 in Rodents. International Journal of Obesity, 39, 424-429. https://doi.org/10.1038/ijo.2014.153
|
[11]
|
Zhao, L., Zhang, F., Ding, X., Wu, G., Lam, Y.Y., Wang, X., et al. (2018) Gut Bacteria Selectively Promoted by Dietary Fibers Alleviate Type 2 Diabetes. Science, 359, 1151-1156. https://doi.org/10.1126/science.aao5774
|
[12]
|
Mano, F., Ikeda, K., Joo, E., Fujita, Y., Yamane, S., Harada, N., et al. (2018) The Effect of White Rice and White Bread as Staple Foods on Gut Microbiota and Host Metabolism. Nutrients, 10, Article No. 1323.
https://doi.org/10.3390/nu10091323
|
[13]
|
Annika, W., Petia, K.-D., Marcus, S., Bäckhed, F. and Marschall, H.-U. (2017) Crosstalk between Bile Acids and Gut Microbiota and Its Impact on Farnesoid X Receptor Signalling. Digestive Diseases, 35, 246-250.
https://doi.org/10.1159/000450982
|
[14]
|
Brønden, A., Albér, A., Rohde, U., Gasbjerg, L.S., Rehfeld, J.F., Holst, J.J., et al. (2018) The Bile Acid-Sequestering Resin Sevelamer Eliminates the Acute GLP-1 Stimulatory Effect of Endogenously Released Bile Acids in Patients with Type 2 Diabetes. Diabetes, Obesity & Metabolism, 20, 362-369. https://doi.org/10.1111/dom.13080
|
[15]
|
Just, S., Mondot, S., Ecker, J., Wegner, K., Rath, E., Gau, L., et al. (2018) The Gut Microbiota Drives the Impact of Bile Acids and Fat Source in Diet on Mouse Metabolism. Microbiome, 6, Article No. 134.
https://doi.org/10.1186/s40168-018-0510-8
|
[16]
|
Yanyun, G., Xiaokai, W., Junhua, L., Zhang, Y., Zhong, H., Liu, R., et al. (2017) Analyses of Gut Microbiota and Plasma Bile Acids Enable Stratification of Patients for Antidiabetic Treatment. Nature Communications, 8, Article No. 1785. https://doi.org/10.1038/s41467-017-01682-2
|
[17]
|
Rong, B., Xia, T., Zhang, T., Feng, R., Huang, H., Wu, Q., et al. (2019) Gut Microbiota: A Potential Manipulator for Host Adipose Tissue and Energy Metabolism. The Journal of Nutritional Biochemistry, 64, 206-217.
https://doi.org/10.1016/j.jnutbio.2018.10.020
|
[18]
|
Nicolucci, A.C., Hume, M.P., Martínez, I., Mayengbam, S., Walter, J. and Reimer, R.A. (2017) Prebiotics Reduce Body Fat and Alter Intestinal Microbiota in Children Who Are Overweight or with Obesity. Gastroenterology, 153, 711-722. https://doi.org/10.1053/j.gastro.2017.05.055
|
[19]
|
Ramos-Molina, B., Sánchez-Alcoholado, L., Cabrera-Mulero, A., Lopez-Dominguez, R., Carmona-Saez, P., Garcia-Fuentes, E., et al. (2019) Gut Microbiota Composition Is Associated with the Global DNA Methylation Pattern in Obesity. Frontiers in Genetics, 10, Article No. 613. https://doi.org/10.3389/fgene.2019.00613
|
[20]
|
Liu, R., Hong, J., Xu, X., Feng, Q., Zhang, D., Gu, Y., et al. (2017) Gut Microbiome and Serum Metabolome Alterations in Obesity and after Weight-Loss Intervention. Nature Medicine, 23, 859-868. https://doi.org/10.1038/nm.4358
|
[21]
|
Li, J., Zhao, F., Wang, Y., Chen, J., Tao, J., Tian, G., et al. (2017) Gut Microbiota Dysbiosis Contributes to the Development of Hypertension. Microbiome, 5, Article No. 14. https://doi.org/10.1186/s40168-016-0222-x
|
[22]
|
Adnan, S., Nelson, J.W., Ajami, N.J., Venna, V.R., Petrosino, J.F., Bryan Jr., R.M., et al. (2017) Alterations in the Gut Microbiota Can Elicit Hypertension in Rats. Physiological Genomics, 49, 96-104.
https://doi.org/10.1152/physiolgenomics.00081.2016
|
[23]
|
Xie, D., Zhang, M., Wang, B., Lin, H., Wu, E., Zhao, H., et al. (2019) Differential Analysis of Hypertension-Associated Intestinal Microbiota. International Journal of Medical Sciences, 16, 872-881. https://doi.org/10.7150/ijms.29322
|
[24]
|
Liu, B., Zhang, Y., Wang, R., An, Y., Gao, W., Bai, L., et al. (2018) Western Diet Feeding Influences Gut Microbiota Profiles in apoE Knockout Mice. Lipids in Health and Disease, 17, Article No. 159.
https://doi.org/10.1186/s12944-018-0811-8
|
[25]
|
Poppleton, D.I., Duchateau, M., Hourdel, V., Matondo, M., Flechsler, J., Klingl, A., et al. (2017) Outer Membrane Proteome of Veillonella parvula: A Diderm Firmicute of the Human Microbiome. Frontiers in Microbiology, 8, Article No. 1215. https://doi.org/10.3389/fmicb.2017.01215
|
[26]
|
Romano, K.A., Vivas, E.I., Amador-Noguez, D. and Rey, F.E. (2015) Intestinal Microbiota Composition Modulates Choline Bioavailability from Diet and Accumulation of the Proatherogenic Metabolite Trimethylamine-N-Oxide. mBio, 6, e02481. https://doi.org/10.1128/mBio.02481-14
|
[27]
|
Chen, X., D’Souza, R. and Hong, S.-T. (2013) The Role of Gut Microbiota in the Gut-Brain Axis: Current Challenges and Perspectives. Protein & Cell, 4, 403-414. https://doi.org/10.1007/s13238-013-3017-x
|
[28]
|
Zhu, W., Buffa, J.A., Wang, Z., Warrier, M., Schugar, R., Shih, D.M., et al. (2018) Flavin Monooxygenase 3, the Host Hepatic Enzyme in the Metaorganismal Trimethylamine N-Oxide-Generating Pathway, Modulates Platelet Responsiveness and Thrombosis Risk. Journal of Thrombosis and Haemostasis, 16, 1857-1872.
https://doi.org/10.1111/jth.14234
|
[29]
|
Nie, J., Xie, L., Zhao, B.X., Li, Y., Qiu, B., Zhu, F., et al. (2018) Serum Trimethylamine N-Oxide Concentration Is Positively Associated with First Stroke in Hypertensive Patients. Stroke, 49, 2021-2028.
https://doi.org/10.1161/strokeaha.118.021997
|
[30]
|
Wang, Z., Klipfell, E., Bennett, B.J., Koeth, R., Levison, B.S., DuGar, B., et al. (2011) Gut Flora Metabolism of Phosphatidylcholine Promotes Cardiovascular Disease. Nature, 472, 57-63. https://doi.org/10.1038/nature09922
|
[31]
|
Koeth, R.A., Levison, B.S., Culley, M.K., Buffa, J.A., Wang, Z., Gregory, J.C., et al. (2014) γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L-Carnitine to TMAO. Cell Metabolism, 20, 799-812.
https://doi.org/10.1016/j.cmet.2014.10.006
|
[32]
|
Senthong, V., Li, X.S., Hudec, T., Coughlin, J., Wu, Y., Levison, B., et al. (2016) Plasma Trimethylamine N-Oxide, a Gut Microbe-Generated Phosphatidylcholine Metabolite, Is Associated with Atherosclerotic Burden. Journal of the American College of Cardiology, 67, 2620-2628. https://doi.org/10.1016/j.jacc.2016.03.546
|
[33]
|
Tang, W.H., Wang, Z. and Levison, B.S. (2013) Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk. Journal of Vascular Surgery, 58, 549. https://doi.org/10.1016/j.jvs.2013.06.007
|
[34]
|
Singh, V., Sadler, R., Heindl, S., Llovera, G., Roth, S., Benakis, C., et al. (2018) The Gut Microbiome primes a Cerebroprotective Immune Response after Stroke. Journal of Cerebral Blood Flow & Metabolism, 38, 1293-1298.
https://doi.org/10.1177/0271678X18780130
|
[35]
|
Yin, J., Liao, S.X., He, Y., Wang, S., Xia, G.H., Liu, F.T., et al. (2015) Dysbiosis of Gut Microbiota with Reduced Trimethylamine-N-Oxide Level in Patients with Large-Artery Atherosclerotic Stroke or Transient Ischemic Attack. Journal of the American Heart Association, 4, e002699. https://doi.org/10.1161/JAHA.115.002699
|
[36]
|
Spychala, M.S., Venna, V.R., Jandzinski, M., Doran, S.J., Durgan, D.J., Ganesh, B.P., et al. (2018) Age-Related Changes in the Gut Microbiota Influence Systemic inflammation and stroke outcome. Annals of Neurology, 84, 23-36.
https://doi.org/10.1002/ana.25250
|
[37]
|
Vikramjeet, S., Stefan, R., Gemma, L., Sadler, R., Garzetti, D., Stecher, B., et al. (2016) Microbiota Dysbiosis Controls the Neuroinflammatory Response after Stroke. The Journal of Neuroscienc, 36, 7428-7440.
https://doi.org/10.1523/JNEUROSCI.1114-16.2016
|
[38]
|
Sadler, R. and Liesz, A. (2020). Short-Chain Fatty Acids Improve Poststroke Recovery via Immunological Mechanisms. Journal of Neuroscience, 40, 1162-1173. https://doi.org/10.1523/JNEUROSCI.1359-19.2019
|
[39]
|
Koh, A., Vadder, F.D., Kovatcheva-Datchary, P. and Bäckhe, F. (2016) From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites. Cell, 165, 1332-1345. https://doi.org/10.1016/j.cell.2016.05.041
|
[40]
|
Chen, R., Xu, Y., Wu, P., Zhou, H., Lasanajak, Y., Fang, Y., et al. (2019) Transplantation of Fecal Microbiota Rich in Short Chain Fatty Acids and Butyric Acid Treat Cerebral Ischemic Stroke by Regulating Gut Microbiota. Pharmacological Research, 148, Article ID: 104403. https://doi.org/10.1016/j.phrs.2019.104403
|
[41]
|
胡诗浩, 杨旭萍, 刘佩芳, 黄寅. 脑卒中并发应激性溃疡的研究进展[J]. 中国医药科学, 2019, 9(16): 47-50+135.
|
[42]
|
Li, B., Lee, C., Filler, T., Hock, A., Wu, R.Y., Li, Q., et al. (2017) Inhibition of Corticotropin-Releasing Hormone Receptor 1 and Activation of Receptor 2 Protect against Colonic Injury and Promote Epithelium Repair. Scientific Reports, 7, Article No. 46616. https://doi.org/10.1038/srep46616
|
[43]
|
Stanley, D., Mason, L.J., Mackin, K.E., Srikhanta, Y.N, Lyras, D., Prakash, M.D, et al. (2016) Translocation and Dissemination of Commensal Bacteria in Post-Stroke Infection. Nature Medicine, 22, 1277-1284.
https://doi.org/10.1038/nm.4194
|